Bristol-Myers Squibb Co (BMY)
55.29
+0.97
(+1.79%)
USD |
NYSE |
Nov 04, 12:58
Bristol-Myers Squibb Gross Profit Margin (Quarterly): 75.13% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 75.13% |
| June 30, 2024 | 73.22% |
| March 31, 2024 | 75.29% |
| December 31, 2023 | 76.08% |
| September 30, 2023 | 77.15% |
| June 30, 2023 | 74.38% |
| March 31, 2023 | 77.37% |
| December 31, 2022 | 77.27% |
| September 30, 2022 | 79.02% |
| June 30, 2022 | 77.12% |
| March 31, 2022 | 78.79% |
| December 31, 2021 | 80.34% |
| September 30, 2021 | 80.29% |
| June 30, 2021 | 79.05% |
| March 31, 2021 | 74.34% |
| December 31, 2020 | 73.71% |
| September 30, 2020 | 76.26% |
| June 30, 2020 | 73.35% |
| March 31, 2020 | 66.03% |
| December 31, 2019 | 68.63% |
| September 30, 2019 | 70.20% |
| June 30, 2019 | 68.56% |
| March 31, 2019 | 69.19% |
| December 31, 2018 | 73.05% |
| September 30, 2018 | 71.04% |
| Date | Value |
|---|---|
| June 30, 2018 | 71.51% |
| March 31, 2018 | 69.50% |
| December 31, 2017 | 70.62% |
| September 30, 2017 | 69.95% |
| June 30, 2017 | 69.50% |
| March 31, 2017 | 74.34% |
| December 31, 2016 | 73.18% |
| September 30, 2016 | 73.49% |
| June 30, 2016 | 75.24% |
| March 31, 2016 | 76.04% |
| December 31, 2015 | 77.79% |
| September 30, 2015 | 73.04% |
| June 30, 2015 | 75.67% |
| March 31, 2015 | 79.04% |
| December 31, 2014 | 77.31% |
| September 30, 2014 | 74.32% |
| June 30, 2014 | 74.52% |
| March 31, 2014 | 74.60% |
| December 31, 2013 | 71.34% |
| September 30, 2013 | 71.09% |
| June 30, 2013 | 72.63% |
| March 31, 2013 | 72.25% |
| December 31, 2012 | 74.35% |
| September 30, 2012 | 73.58% |
| June 30, 2012 | 71.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
66.03%
Minimum
Mar 2020
80.34%
Maximum
Dec 2021
75.64%
Average
76.17%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 61.07% |
| Johnson & Johnson | 69.01% |
| Eli Lilly and Co | 81.02% |
| Merck & Co Inc | 75.51% |
| Pfizer Inc | 70.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.18% |
| Return on Assets | -7.66% |
| Return on Invested Capital | -10.53% |
| Profit Margin (Quarterly) | 10.18% |
| Operating Margin (Quarterly) | 18.26% |
| Return on Net Operating Assets | -9.43% |